AG003K1L

152121-47-6 | 4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole

AG003K1L

SDS

COA

Price

$0.00

Add to Cart

Buy Now

WARNING This product is not for human or veterinary use.

CAS Number	152121-47-6
Catalog Number	AG003K1L(AGN-PC-05WHJ0)
Chemical Name	4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole
IUPAC Name	4-[4-(4-fluorophenyl)-2-(4-methylsulfinylphenyl)-1H-imidazol-5-yl]pyridine
InChI	InChI=1S/C21H16FN3OS/c1-27(26)18-8-4-16(5-9-18)21-24-19(14-2-6-17(22)7-3-14)20(25-21)15-10-12-23-13-11-15/h2-13H,1H3,(H,24,25)
InChI Key	CDMGBJANTYXAIV-UHFFFAOYSA-N
MDL Number	MFCD00922198
Molecular Formula	C21H16FN3OS
Molecular Weight	377.4346
SMILES	FC1=CC=C(C=C1)C=1N=C(NC1C1=CC=NC=C1)C1=CC=C(C=C1)S(=O)C
Synonyms	4-(4-fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole, pyridine, 4-(5-(4-fluorophenyl)-2-(4-(methylsulfinyl)phenyl)-1H-imidazol-4-yl)-, SB 203580, SB-203580, SB203580, 152121-47-6, SB 203580, SB-203580, SB203580, 4-(4-(4-fluorophenyl)-2-(4-(methylsulfinyl)phenyl)-1H-imidazol-5-yl)pyridine, RWJ 64809, 4-(4-Fluorophenyl)-2-[4-(methylsulfinyl)phenyl]-5-(4-pyridyl)-1H-imidazole, CHEBI:90705, 4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole, CHEMBL10, 4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)1H-imidazole, 4-[4-(4-fluorophenyl)-2-(4-methylsulfinylphenyl)-1H-imidazol-5-yl]pyridine, PB 203580, InSolution™ SB 203580, MFCD00922198, UNII-WS78QR6DSV, 4-(4-(4-Fluorophenyl)-2-(4-(methylsulfinyl)-phenyl)-1H-imidazol-5-yl)pyridine, 4-(5-(4-fluorophenyl)-2-(4-(methylsulfinyl)phenyl)-1H-imidazol-4-yl)pyridine, Pyridine, 4-(5-(4-fluorophenyl)-2-(4-(methylsulfinyl)phenyl)-1H-imidazol-4-yl)-, C21H16FN3OS, UNII-2Z5A7553WW, 4-[4-(4-fluorophenyl)-2-(4-methanesulfinylphenyl)-1H-imidazol-5-yl]pyridine, 4-[5-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-3H-imidazol-4-yl]pyridine, 4-{4-(4-fluorophenyl)-2-[4-(methylsulfinyl)phenyl]-1H-imidazol-5-yl}pyridine, WS78QR6DSV, 2Z5A7553WW, SR-01000597367, 1pme, Kinome_2521, RWJ-64809, (R)-, RWJ-64809, (S)-, Tocris-1202, Tocris-1402, BIRB-203580, (R)-, BIRB-203580, (S)-, PB-203580, (R)-, PB-203580, (S)-, SB-203580, (R)-, SB-203580, (S)-, cc-50, AC1L41YG, CBiol_001970, SCHEMBL95208, BSPBio_001104, MLS006010840, cid_176155, GTPL5269, DTXSID2040577, BDBM13336, CTK7C0221, CTK8E9223, AOB6367, BIS0733, EX-A134, SYN1074, 4-[5-(4-FLUORO-PHENYL)-2-(4-METHANESULFINYL-PHENYL)-3H-IMIDAZOL-4-YL]-PYRIDINE, 4-[5-(4-FLUORO-PHENYL)-2-[4-METHANESULFINYL-PHENYL]-3H-IMIDAZOL-4-YL]-PYRIDINE, CDMGBJANTYXAIV-UHFFFAOYSA-N, ZX-AFC000489, BCPP000074, BDBM192501, Bio1_000256, Bio1_000745, Bio1_001234, HMS1792H05, HMS1990H05, HMS3229O04, HMS3244I15, HMS3244I16, HMS3244J15, HMS3267B07, HMS3403H05, HMS3654M15, HMS3676M17, BCP01763, KS-000018EO, ABP000230, ANW-72176, BDBM50045333, BS0218, CF-031, GK9716, RS0055, s1076, AKOS005145971, AKOS015994568, AM81234, CCG-206878, CS-0140, ES-0013, RTC-063053, RWJ-64809;, SB16633, TRA0064819, Pyridine, 4-(4-(4-fluorophenyl)-2-(5-((R)-methylsulfinyl)phenyl)-1H-imidazol-4-yl)-, Pyridine, 4-(4-(4-fluorophenyl)-2-(5-((S)-methylsulfinyl)phenyl)-1H-imidazol-4-yl)-, NCGC00025035-01, NCGC00025035-02, NCGC00025035-03, NCGC00025035-04, NCGC00025035-05, NCGC00381704-12, 4CA-1136, 652162-77-1, 896734-47-7, AK-51369, HY-10256, QC-11773, SC-27890, SMR004701767, AB0033710, AX8150875, DB-026130, LS-186976, LS-187618, TC-063053, TC-160921, FT-0674525, SW218141-2, X7403, EC-000.2318, SB203580/SB-203580, K00038, S-7702, SB 203580, solid, >=98% (HPLC), SB 203580 & Z-100, 121S476, J-008891, J-513573, SR-01000597367-1, 4-(4-Fluorophenyl)-2-[4-(methylsulfinyl)phenyl]-5-, BRD-A37704979-001-02-4, BRD-A37704979-003-01-2, I14-10276, SB203580,RWJ 64809,PB 203580, US9187470, 104 (SB203580), RWJ 64809, PB 203580, 152121-47-6, 4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazol, 4-(4-fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)imidazole, 4-[5-(4-fluorophenyl)-2-(4-methanesulfinylphenyl)-3H-imidazol-4-yl]pyridine, 4-{4-(4-fluorophenyl)-2-[4-(methanesulfinyl)phenyl]-1H-imidazol-5-yl}pyridine, Pyridine, 4-[4-(4-fluorophenyl)-2-[4-(methylsulfinyl)phenyl]-1H-imidazol-5-yl]-, Pyridine, 4-[5-(4-fluorophenyl)-2-[4-(methylsulfinyl)phenyl]-1H-imidazol-yl]-, Pyridine, 4-[5-(4-fluorophenyl)-2-[4-(methylsulfinyl)phenyl]-1H-imidazol-yl]- & Z-100, RWJ-64809|||PB-203580|||4-[4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-1H-imidazol-5-yl]pyridine, UNII-OU13V1EYWQ, OU13V1EYWQ, D0F8DL, AN-448, CID176155, SB202190, A8254, A15256, C093642, SB 203580, 98% - 100MG 100mg, 4-[5-(4-Fluorophenyl)-2-[4-(methylsulfonyl)phenyl]-1H-imidazol-4-yl]pyridine,

Complexity	500
Compound Is Canonicalized	Yes
Covalently-Bonded Unit Count	1
Defined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Exact Mass	377.1g/mol
Formal Charge	0
Heavy Atom Count	27
Hydrogen Bond Acceptor Count	5
Hydrogen Bond Donor Count	1
Isotope Atom Count	0
Molecular Weight	377.437g/mol
Monoisotopic Mass	377.1g/mol
Rotatable Bond Count	4
Topological Polar Surface Area	77.8A^2
Undefined Atom Stereocenter Count	1
Undefined Bond Stereocenter Count	0
XLogP3	3.2

GHS Hazard and Precautionary Statements

Symbol:
Hazard Class
Hazard statements	H302-H319
Packing Group
Precautionary statements	P305+P351+P338
UN Code

Certificate of Analysis

Lot Number